ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Former HHS Official Could Replace Heckler, Reagan Signs Federal Cigarette Tax Extension

October 11, 1985

Fisher, Redmond Removed Fro Official posts At NSABP

May 13, 1994

Two Cooperative Groups Renamed ECOG-ACRIN

September 23, 2011

Grants Funding: FY(& Year-End Report By NCI On Paylines

October 10, 1997

Greenwald: Report’s Implementation Will Require Budget Raise

June 27, 1997

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976